Xiaopeng Guo

2.4k citations
127 papers · 1.4k indexed · h-index 22

Impact in

Papers in

Xiaopeng Guo

112 papers receiving 1.4k citations

Peers

Xiaopeng Guo
Comparison fields: 5 of 145
  • Endocrinology, Diabetes and Metabolism 545
  • Genetics 274
  • Cancer Research 207
  • Pulmonary and Respiratory Medicine 239
  • Health Informatics 8
Replace Yong Yao with:
Yong Yao China
Yu‐Ting Huang Taiwan
Heyu Zhang China
Jun Jiang China
Ignacio Aranda Spain
Jun Pan China
Woo Chan Park South Korea
Tae Hoon Roh South Korea
Heide Siggelkow Germany
Oliver Groß Germany
Xiaopeng Guo relative to Yong Yao China Yong Yao's profile →
Citations per field
00.5×
Yong Yao · 1×
Citations per year

Countries citing papers authored by Xiaopeng Guo

Since Specialization
Citations

This map shows the geographic impact of Xiaopeng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopeng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopeng Guo more than expected).

Fields of papers citing papers by Xiaopeng Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaopeng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopeng Guo. The network helps show where Xiaopeng Guo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xiaopeng Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaopeng Guo Line = papers co-authored together Xiaopeng Guo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20252
3 20251
4 20250
5 20250
6 20241
7 20240
8 20237
9 20232
10 202324
11 20238
12 202340
13 20233
14 20221
15 20202
16 20194
17 201917
18 201814
19 20181
20 201720

About Xiaopeng Guo

Xiaopeng Guo is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Microbiology, Cancer Research and Neurology, having authored 127 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (63 papers), Growth Hormone and Insulin-like Growth Factors (33 papers), Glioma Diagnosis and Treatment (27 papers), Adrenal and Paraganglionic Tumors (19 papers), TGF-β signaling in diseases (8 papers), Ferroptosis and cancer prognosis (8 papers), Meningioma and schwannoma management (7 papers) and Ophthalmology and Eye Disorders (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (545 citations), Genetics (274 citations), Cancer Research (207 citations), Pulmonary and Respiratory Medicine (239 citations) and Health Informatics (8 citations). Xiaopeng Guo has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Bing Xing, Lu Gao, Zihao Wang, Wei Lian, Kan Deng, Wenbin Ma, Chenzhe Feng, Zihao Wang, Yu Wang and Dongfang Ren. Their work appears in journals such as World Neurosurgery, Frontiers in Endocrinology, Frontiers in Oncology, The Journal of Clinical Endocrinology & Metabolism and Pituitary.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026